90 related articles for article (PubMed ID: 2511724)
1. Acute nonlymphocytic leukemia: evidence of clonogenic cells in peripheral blood in early complete remission.
Castagnola C; Bonfichi M; Colombo A; Bernasconi P; Bernasconi C
Acta Haematol; 1989; 82(4):210-2. PubMed ID: 2511724
[TBL] [Abstract][Full Text] [Related]
2. Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2).
Farag S; Challis J; White J; Garson OM
Cancer Genet Cytogenet; 1992 Jan; 58(1):48-51. PubMed ID: 1728949
[TBL] [Abstract][Full Text] [Related]
3. The role of peripheral blood stem cells as rescue after myeloablative therapy.
Reiffers J; Marit G; Boiron JM; Rice A; Bernard P; Vezon G
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():212-4. PubMed ID: 2565746
[No Abstract] [Full Text] [Related]
4. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
[No Abstract] [Full Text] [Related]
5. [Individualized chemotherapy of adult acute nonlymphocytic leukemia].
Uzuka Y; Saito Y
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1473-80. PubMed ID: 2389943
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
[No Abstract] [Full Text] [Related]
7. [DCTP(II) combination chemotherapy of adult acute nonlymphocytic leukemia].
Kobayashi T; Ogawa M; Kuraishi Y; Nagata T; Aiba K; Nakamura T; Usui N; Yamazaki H; Ichiba K; Isogai Y
Nihon Ketsueki Gakkai Zasshi; 1988 Aug; 51(5):855-63. PubMed ID: 3206983
[No Abstract] [Full Text] [Related]
8. [A regimen of DATV in the treatment of acute nonlymphocytic leukemia with high complete remission rate].
Lou FD; Zhou Q; Meng FY
Zhonghua Nei Ke Za Zhi; 1992 Mar; 31(3):146-8, 187. PubMed ID: 1395925
[TBL] [Abstract][Full Text] [Related]
9. The optimization of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia.
To LB; Haylock DN; Thorp D; Dyson PG; Branford AL; Ho JQ; Dart GD; Roberts MM; Horvath N; Bardy P
Bone Marrow Transplant; 1989 Jan; 4(1):41-7. PubMed ID: 2564287
[TBL] [Abstract][Full Text] [Related]
10. Randomized multicenter trial of cytosine arabinoside with mitoxantrone or daunorubicin in previously untreated adult patients with acute nonlymphocytic leukemia (ANLL). Lederle Cooperative Group.
Arlin Z; Case DC; Moore J; Wiernik P; Feldman E; Saletan S; Desai P; Sia L; Cartwright K
Leukemia; 1990 Mar; 4(3):177-83. PubMed ID: 2179638
[TBL] [Abstract][Full Text] [Related]
11. [A case of acute nonlymphocytic leukemia with leukemic cell infiltration to the uterus followed by bone marrow relapse].
Shiga Y; Shichishima T; Aikawa K; Gotoh J; Furukawa T; Yamagiwa A; Ishibashi T; Maruyama Y
Rinsho Ketsueki; 1994 May; 35(5):501-5. PubMed ID: 8028198
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of acute nonlymphocytic leukemia].
Preĭsler KhD; Raza A
Gematol Transfuziol; 1991 Jan; 36(1):3-8. PubMed ID: 2065944
[No Abstract] [Full Text] [Related]
13. Prediction of induction and duration of complete remission in acute myelogenous leukemia: value of clonogenic cell properties.
Zittoun R; Marie JP; Brilhante D; Delmer A
Haematol Blood Transfus; 1987; 30():45-9. PubMed ID: 3476378
[No Abstract] [Full Text] [Related]
14. High-dose cytosine arabinoside as consolidation chemotherapy for acute nonlymphocytic leukemia in remission.
Urabe A; Mizoguchi H; Hoshino S; Nomura T; Dan K; Toyama K; Kimura M; Ogawa T; Yamaguchi H; Mutoh Y
Int J Hematol; 1991 Feb; 54(1):75-7. PubMed ID: 1954354
[TBL] [Abstract][Full Text] [Related]
15. Comparative trial of cytarabine and thioguanine in combination with amsacrine or daunorubicin in patients with untreated acute nonlymphocytic leukemia: results of the L-16M protocol.
Berman E; Arlin ZA; Gaynor J; Miller W; Gee T; Kempin SJ; Mertelsmann R; Andreeff M; Reich L; Nahmias N
Leukemia; 1989 Feb; 3(2):115-21. PubMed ID: 2911205
[TBL] [Abstract][Full Text] [Related]
16. Unfavourable outcome of a patient with M2 acute non lymphocytic leukemia and a 47,XY,t(5;7)(q34;q21), +8 karyotype.
Testoni N; Zaccaria A; Celso B; Tura S
Haematologica; 1991; 76(1):65-8. PubMed ID: 2055562
[TBL] [Abstract][Full Text] [Related]
17. High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trial.
Willemze R; Suciu S; Meloni G; Labar B; Marie JP; Halkes CJ; Muus P; Mistrik M; Amadori S; Specchia G; Fabbiano F; Nobile F; Sborgia M; Camera A; Selleslag DL; Lefrère F; Magro D; Sica S; Cantore N; Beksac M; Berneman Z; Thomas X; Melillo L; Guimaraes JE; Leoni P; Luppi M; Mitra ME; Bron D; Fillet G; Marijt EW; Venditti A; Hagemeijer A; Mancini M; Jansen J; Cilloni D; Meert L; Fazi P; Vignetti M; Trisolini SM; Mandelli F; de Witte T
J Clin Oncol; 2014 Jan; 32(3):219-28. PubMed ID: 24297940
[TBL] [Abstract][Full Text] [Related]
18. Idarubicin is superior to daunorubicin in remission induction of de novo acute myeloid leukemia patients with high MDR1 expression.
Shi P; Zha J; Guo X; Chen F; Fan Z; Huang F; Meng F; Liu X; Feng R; Xu B
Pharmacogenomics; 2013 Jan; 14(1):17-23. PubMed ID: 23252945
[TBL] [Abstract][Full Text] [Related]
19. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
20. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
